The relationship between nerve fiber layer and perimetry measurements

Investigative Ophthalmology and Visual Science

Volumn 48, Issue 2, 2007, Pages 763-773

  Harwerth, Ronald S ^a,b   Vilupuru, Abhiram S ^a   Rangaswamy, Nalini V ^a   Smith III, Earl L ^a  

^a UNIVERSITY OF HOUSTON   (United States)

^b UNIVERSITY OF HOUSTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANALYZER; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL LOSS; CONTROLLED STUDY; CORRELATION ANALYSIS; GLAUCOMA; LASER; MONKEY; NERVE FIBER; NONHUMAN; OPTIC NERVE; OPTICAL COHERENCE TOMOGRAPHY; PERIMETRY; PRIORITY JOURNAL; RETINA GANGLION CELL; RETINA NERVE CELL; RETINA NEUROEPITHELIAL LAYER; VISUAL FIELD; VISUAL FIELD DEFECT; ANIMAL; CELL COUNT; DISEASE MODEL; MACACA; OPTIC DISK; OPTIC NERVE DISEASE; PATHOLOGY; VISUAL DISORDER;

ANIMALS; CELL COUNT; DISEASE MODELS, ANIMAL; GLAUCOMA; MACACA MULATTA; NERVE FIBERS; OPTIC DISK; OPTIC NERVE DISEASES; PERIMETRY; RETINAL GANGLION CELLS; TOMOGRAPHY, OPTICAL COHERENCE; VISION DISORDERS; VISUAL FIELDS;

EID: 33847709892     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: 10.1167/iovs.06-0688     Document Type: Article

References (77)

1. Epstein DL. Primary open angle glaucoma. In: Epstein DL, Allingham RR, Schuman JS, eds. Chandler and Grant's Glaucoma, 4th ed. Baltimore: Williams & Wilkins; 1993:183-198.
2. Quigley HA. Open-angle glaucoma. N Engl J Med. 1993;328:1097-1106.
3. Anderson DR. Perimetry, with and without Automation. 2nd ed. St. Louis: CV Mosby, Co.; 1987.
4. Quigley HA. Neuronal death in glaucoma. Prog Retinal Eye Res. 1995;18:39-57.
5. Nickells RW. Retinal ganglion cell death in glaucoma: the how, the why, and the maybe. J Glaucoma. 1996;5:345-356.
6. Weinreb RN. Primary open-angle glaucoma. Lancet. 2004;363:1711-1720.
7. Johnson CA. Standardizing the measurement of visual fields for clinical research. Ophthalmology. 1996;103:186-189.
8. Greenfeld DS. Optic nerve and retinal nerve fiber analyzers in glaucoma. Curr Opin Ophthalmol. 2002;13:68-76.
9. Zangwill LM, Bowd C. Retinal nerve fiber layer analysis in the diagnosis of glaucoma. Curr Opin Ophthalmol. 2006;17:120-131.
10. Hee MR, Izatt JA, Swanson EA, et al. Optical coherence tomography of the human retina. Arch Ophthalmol. 1995;113:325-332.
11. Fujimoto JG, Hee MR, Huang D, et al. Optical coherence tomography of ocular diseases. In: Schuman JS, Puliafito CA, Fujimoto JG, eds. Principles of Optical Coherence Tomography. 2nd ed. Thorofare, NJ: Slack, Inc.; 2004:3-19.
12. Quigley HA, Dunkelberger GR, Green WR. Retinal ganglion cell atrophy correlated with automated perimetry in human eyes with glaucoma. Am J Ophthalmol. 1989;107:453-464.
13. Kerrigan-Baumrind LA, Quigley HA, Pease ME, et al. Number of ganglion cells in glaucoma eyes compared with threshold visual field tests in the same persons. Invest Ophthalmol Vis Sci. 2000;41:741-748.
14. Harwerth RS, Carter-Dawson L, Smith EL III, et al. Neural losses correlated with visual losses in clinical perimetry. Invest Ophthalmol Vis Sci. 2004;45:3152-3160.
15. Harwerth RS, Quigley HA. Visual field defects and retinal ganglion cell losses in patients with glaucoma. Arch Ophthalmol. 2006;124:853-859.
16. Budenz DL, Chang RT, Huang X, et al. Reproducibility of retinal nerve fiber layer thickness measurements using the StratusOCT in normal and glaucomatous eyes. Invest Ophthalmol Vis Sci. 2005;46:2440-2443.
17. Budenz, DL, Michael A, Chang RT, et al. Sensitivity and specificity of the StratusOCT for perimetric glaucoma. Ophthalmology. 2005;112:3-9.
18. Chen HY, Huang ML. Discrimination between normal and glaucomatous eyes using Stratus optical coherence tomography in Taiwan Chinese subjects. Graefes Arch Clin Exp Ophthalmol. 2005;243:894-902.
19. Sihota R, Sony P, Gupta V, et al. Comparing glaucomatous optic neuropathy in primary open angle and chronic primary angle closure glaucoma eyes by optical coherence tomography. Ophthalmic Physiol Opt. 2005;25:408-415.
20. Mederios FA, Zangwill LM, Bowd C, et al. Influence of disease severity and optic disc size on the diagnostic performance of imaging instruments in glaucoma. Invest Ophthalmol Vis Sci. 2006;47:1008-1015.
21. Sihota R, Sony P, Gupta V. Diagnostic capability of optical coherence tomography in evaluating the degree of glaucomatous retinal nerve fiber damage. Invest Ophthalmol Vis Sci. 2006;47:2006-2010.
22. Sommer A, Katz J, Quigley HA. Clinically detectable nerve fiber layer atrophy precedes the onset of glaucomatous field loss. Arch Ophthalmol. 1991;199:77-81.
23. Wollstein G, Beaton S, Paunescu A. Optical coherence tomography in glaucoma. In: Schuman JS, Puliafito CA, Fujimoto JG, eds. Optical Coherence Tomography of Ocular Diseases. 2nd ed. Thorofare, NJ: Slack, Inc.; 2004:483-610.
24. Wollstein G, Schuman JS, Price LL, et al. Optical coherence tomography longitudinal evaluation of retinal nerve fiber layer thickness in glaucoma. Arch Ophthalmol. 2005;123:464-470.
25. Bowd C, Weinreb RN, Williams JM, et al. The retinal nerve fiber layer thickness in ocular hypertensive, normal, and glaucomatous eyes with optical coherence tomography. Arch Ophthalmol. 2000;118:22-26.
26. Matsumoto C, Shirato S, Haneda M, et al. Study of retinal nerve fiber layer thickness within normal; hemivisual field in primary open-angle glaucoma and normal-tension glaucoma. Jpn J Ophthalmol. 2003;47:22-27.
27. Mohammadi K, Bowd C, Weinreb RN, et al. Retinal nerve fiber layer thickness measurements with scanning laser polarimetry predict glaucomatous visual field loss. Am J Ophthalmol. 2004;138:592-601.
28. Bagga H, Feuer WJ, Greenfield DS. Detection of psychophysical and structural injury in eyes with glaucomatous optic neuropathy and normal standard automated perimetry. Arch Ophthalmol. 2006;124:169-176.
29. Bowd C, Zangwill LM, Berry CC, et al. Detecting early glaucoma by assessment of retinal nerve fiber layer thickness and visual function. Invest Ophthalmol Vis Sci. 2001;42:1993-2003.
30. Harwerth RS, Smith EL, DeSantis L. Behavioral perimetry in monkeys. Invest Ophthalmol Vis Sci. 1993;34:31-40.
31. Harwerth RS, Smith EL, DeSantis L. Mechanisms mediating visual detection in static perimetry. Invest Ophthalmol Vis Sci. 1993;34:3011-3023.
32. Harwerth RS, Carter-Dawson L, Shen F, et al. Ganglion cell losses underlying visual field defects from glaucoma. Invest Ophthalmol Vis Sci. 1999;40:2242-2250.
33. Harwerth RS, Smith EL, Chandler M. Progressive visual field defects from experimental glaucoma: measurements with white and colored stimuli. Optom Vis Sci. 1999;76:558-570.
34. Harwerth RS, Crawford ML, Frishman LJ, et al. Visual field defects and neural losses from experimental glaucoma. Prog Retinal Eye Res. 2002;21:91-125.
35. Harwerth RS, Carter-Dawson L, Smith EL, et al. Scaling the structure-function relationship for clinical perimetry. Acta Ophthalmol Scand. 2005;83:448-455.
36. Quigley HA, Holman RM. Laser energy levels for trabecular meshwork damage in the primate eye. Invest Ophthalmol Vis Sci. 1987;24:1305-1307.
37. Harwerth RS, Smith EL, DeSantis L. Experimental glaucoma: perimetric field defects and intraocular pressure. J Glaucoma. 1997;6:390-401.
38. Gaasterland DE, Kupfer C. Experimental glaucoma in the rhesus monkey. Invest Ophthalmol. 1974;13:455-457.
39. Pederson JE, Gaasterland DE. Laser-induced primate glaucoma. I. Progression of cupping. Arch Ophthalmol. 1984;102:1689-1692.
40. Kee C, Pickett P, Dueker DK, et al. Argon laser trabeculoplasty and pilocarpine effects on outflow facility in cynomolgus monkey. J Glaucoma. 1995;4:334-343.
41. Burgoyne CF, Downs JC, Bellezza AJ, et al. Three-dimensional reconstruction of normal and early glaucoma monkey ONH connective tissues. Invest Ophthalmol Vis Sci. 2004;45:4388-4399.
42. Hare WA, WoldeMussie E, Lai RK, et al. Efficacy and safety of memantine treatment for reduction of changes associated with experimental glaucoma in monkey, I: functional measures. Invest Ophthalmol Vis Sci. 2004;45:2625-2639.
43. Shimazawa M, Tomita G, Taniguchi T, et al. Morphometric evaluation of changes with time in optic disc structure and thickness of retinal nerve fiber layer in chronic ocular hypertensive monkeys. Exp Eye Res. 2006;82:427-440.
44. Frenkel S, Morgan JE, Blumenthal EZ. Histological measurement of retinal nerve fiber layer thickness. Eye. 2005;19:491-498.
45. Savini G, Zanini M, Carelli V, et al. Correlation between retinal nerve fiber layer thickness and ONH size: an optical coherence tomography study. Br J Ophthalmol. 2005;89:489-492.
46. Skaf M, Bernardes AB, Cardillo JA, et al. Retinal nerve fiber layer thickness in normal eyes using third-generation optical coherence tomography. Eye. 2006;20:431-439.
47. Sanchez RM, Dunkelberger GR, Quigley HA. The number and diameter distribution of axons in monkey optic nerve. Invest Ophthalmol Vis Sci. 1986;27:1342-1350.
48. Morrison JC, Cork LC, Dunkelberger GR, et al. Aging changes of the rhesus monkey optic nerve. Invest Ophthalmol Vis Sci. 1990;31:1623-1627.
49. Cull G, Cioffi GA, Dong J, et al. Estimating normal optic nerve axon numbers an non-human primate eyes. J Glaucoma. 2003;12:301-306.
50. Potts AM, Hodges D, Shelman CB, et al. Morphology of the primate optic nerve. I. Method and total fiber count. Invest Ophthalmol Vis Sci. 1972;11:980-988.
51. Kupfer C, Chumbley L, Downer JC. Quantitative histology of optic nerve, optic tract and lateral geniculate nucleus of man. J Anat. 1967;101:393-401.
52. Mikelberg FS, Drance SM, Schulzer M, et al. The normal human optic nerve. Axon count and axon diameter distribution. Ophthalmology. 1989;96:1325-1328.
53. Ogden TE. Nerve fiber layer of the primate retina: morphometric analysis. Invest Ophthalmol Vis Sci. 1984;2519-2529.
54. Repka MX, Quigley HA. The effect of age on normal optic nerve fiber number and diameter. Ophthalmology. 1989;96:26-32.
55. Wang L, Dong J, Cull G, et al. Varicosities of intraretinal ganglion cell axons in human and nonhuman primates. Invest Ophthalmol Vis Sci. 2003;44:2-9.
56. Wirtschafter JD, Becker WL, Howe JB, et al. Glaucoma visual field analysis by computed profile of nerve fiber function in optic disc sectors. Ophthalmology. 1982;89:255-267.
57. Weber J, Ulrich H. A perimetric nerve fiber bundle map. Int Ophthalmol. 1991;15:193-200.
58. Garway-Heath DF, Poinoosawmy D, Fitzke FW, et al. Mapping the visual field to the optic disc in normal tension glaucoma eyes. Ophthalmology. 2000;107:1809-1815.
59. Gardiner SK, Johnson CA, Cioffi GA. Evaluation of the structure-function relationship in glaucoma. Invest Ophthalmol Vis Sci. 2005;46:3712-3717.
60. Heijl A, Lindgren G, Olsson J. A package for the statistical analysis of visual fields. Doc Ophthalmol. 1987;49:153-168.
61. Ogden TE. Nerve fiber layer of the primate retina: thickness and glial content. Vision Res. 1983;23:581-587.
62. Wang L, Cioffi GA, Cull G. Immunohistologic evidence for retinal glial cell changes in human glaucoma. Invest Ophthalmol Vis Sci. 2002;43:1088-1094.
63. Johnson CA. Selective versus non-selective losses in glaucoma. J Glaucoma. 1994;3:32-44.
64. Bosworth CF, Sample PA, Gupta N, et al. Motion automated perimetry identifies early glaucomatous field defects. Arch Ophthalmol. 1998;116:1153-1158.
65. Spry PGD, Johnson CA, Mansberger SL, Cioffi GA. Psychophysical investigation of ganglion cell loss in early glaucoma. J Glaucoma. 2005;14:11-19.
66. Sample PA, Bosworth CF, Blumenthal EZ, et al. Visual function-specific perimetry for indirect comparison of different ganglion cell populations in glaucoma. Invest Ophthalmol Vis Sci. 2000;41;1783-1790.
67. Ansari EA, Morgan JE, Snowden RJ. Glaucoma: squaring the psychophysics and neurobiology. Br J Ophthalmol. 2002;86;823-826.
68. Kadaboukhova L, Lindblom B. Frequency doubling technology and high-pass resolution perimetry in glaucoma and ocular hypertension. Acta Ophthalmol Scand. 2003;81;247-252.
69. Martin L, Wanger P, Vancea L, et al. Concordance of high-pass perimetry and frequency-doubling technology perimetry results in glaucoma: no support for selective ganglion cell damage. J Glaucoma. 2003;12;40-44.
70. Spry PGD, Johnson CA. Identification of progressive glaucomatous visual field loss. Surv Ophthalmol. 2002;47:158-173.
71. Artes PH, Nicolela MT, LeBlanc RP, et al. Visual field progression in glaucoma. Invest Ophthalmol Vis Sci. 2005;46:4600-4606.
72. Dicht A, Jonas JB, Naumann GO. Retinal nerve fiber layer thickness in human eyes. Graefes Arch Clin Exp Ophthalmol. 1999,237: 474-479.
73. Asman P, Heijl A. Glaucoma hemi-field test: automated visual field evaluation. Arch Ophthalmol. 1992;110:812-819.
74. Alamouti B, Funk J. Retinal thickness decreases with age: an OCT study. Br J Ophthalmol. 2003;87:899-901.
75. Kanamori A, Escano MTF, Eno A, et al. Evaluation of the effect of aging on retinal nerve fiber layer thickness measured by optical coherence tomography. Ophthalmologica. 2003;217:273-278.
76. Sony P, Sihota R, Tewari Hem K, et al. Quantification of the retinal nerve fiber layer thickness in normal Indian eyes with optical coherence tomography. Indian J Ophthalmol. 2004;52:303-309.
77. Patella VM. StratusOCT: Establishment of Normative Reference Values for Retinal Nerve Fiber layer Thickness Measurements. Dublin, CA: Carl Zeiss Meditec; 2005.